- Home
- » Tags
- » Tyrosine kinase
Top View
- Novel Roles of Erbb3 Receptor Tyrosine Kinase in Vesicular Trafficking
- Small Molecule Tyrosine Kinase Inhibitors of Erbb2/HER2/Neu in the Treatment of Aggressive Breast Cancer
- Receptor Tyrosine Kinase Signalling As a Target for Cancer Intervention Strategies
- Harnessing the Power of Eph/Ephrin Biosemiotics for Theranostic Applications
- Trastuzumab Is Not a Tyrosine Kinase Inhibitor Nishant Mohan and Wen Jin Wu
- Pdgfrβ Kinase Assay by Jolanta Vidugiriene, Ph.D., Hicham Zegzouti, Ph.D., and Said A
- THE ROLE of the Ret PROTO-ONCOGENE in HUMAN DISEASE
- C-Met and Other Cell Surface Molecules: Interaction, Activation and Functional Consequences
- Clinical Use of Tyrosine Kinase Inhibitors: Therapy for Chronic Myelogenous Leukemia and Other Cancers
- A Tyrosine Kinase-Activating Variant Asn666ser in PDGFRB Causes a Progeria-Like Condition in the Severe End of Penttinen Syndrome
- Mechanisms of Receptor Tyrosine Kinase Activation in Cancer Zhenfang Du1 and Christine M
- Exploiting Insights on the RET Receptor for Personalized Cancer Medicine
- Structure and Regulation of Kit Protein-Tyrosine Kinase—The Stem Cell Factor Receptor Q
- De-Repression of Pdgfrb Transcription Promotes Acquired
- TNF Down-Regulation of Receptor Tyrosine Kinase
- Novel Therapeutic Inhibitors of the C-Met Signaling Pathway in Cancer Joseph Paul Eder,1George F
- Oncogenic Mutation in the Kit Receptor Tyrosine Kinase Alters Substrate
- Erbb3/HER3 Intracellular Domain Is Competent to Bind ATP and Catalyze Autophosphorylation
- Erbb Signaling Interrupted: Targeting Ligand-Induced Pathway Activation Frederick H
- PDZ-Domain-Mediated Interaction of the Eph-Related Receptor Tyrosine Kinase Ephb3 and the Ras-Binding Protein AF6 Depends on the Kinase Activity of the Receptor
- Molecular Mechanisms of Cardiotoxicity Induced by Erbb Receptor Inhibitor Cancer Therapeutics
- Signaling by Non-Canonical Receptor Tyrosine Kinases ERBB3 and RYK
- Eph/Ephrin Molecules—A Hub for Signaling and Endocytosis
- Emerging Roles for Eph Receptors and Ephrin Ligands in Immunity
- Eph Receptor Tyrosine Kinases in Tumor Immunity Eileen Shiuan1,2 and Jin Chen1,3,4,5,6
- Approaches to Manipulate Ephrin-A:Epha Forward Signaling Pathway
- Molecular Pathways Targeting RET Receptor Tyrosine Kinase Activation in Cancer John E. Phay1 and Manisha H. Shah2 Affiliations
- Role of the HGF/C-MET Tyrosine Kinase Inhibitors in Metastasic Melanoma Lucia Demkova and Lucia Kucerova*
- Tyrosine Kinase Activity Is Necessary for Growth Factor-Stimulated Rabbit Type I1 Pneumocyte Proliferation
- KIT Gene KIT Proto-Oncogene Receptor Tyrosine Kinase
- Epithelial Cells and Provides a Regulatory Link to Lung Ephrin-A1
- The Erbb3 Receptor Tyrosine Kinase Negatively Regulates Paneth Cells by PI3K-Dependent Suppression of Atoh1
- Rat Epha2 / Eph Receptor A2 Protein (Fc Tag)
- The Receptor Tyrosine Kinase Erbb3 Maintains the Balance Between Luminal and Basal Breast Epithelium
- In Human Leukemia Cells Ephrin-B–Induced Invasive Activity Is Supported by Lck and Is Associated with Reassembling of Lipid Raft Signaling Complexes
- Insights Into Eph Receptor Tyrosine Kinase Activation from Crystal Structures of the Epha4 Ectodomain and Its Complex with Ephrin-A5
- Knockdown of EPHA1 Using CRISPR/CAS9 Suppresses Aggressive Properties of Ovarian Cancer Cells YUXIN CUI 1* , BO WU 1,2* , VALENTINA FLAMINI 1, BRONWEN A.J
- Expression of C-Kit Gene Products in Known Cellular Targets of W Mutations in Normal and W Mutant Mice--Evidence for an Impaired C-Kit Kinase in Mutant Mice
- Protein Tyrosine Kinase Assay Kit, Non-Radioactive
- Cells and Epha Receptor Down-Regulation in T Ephrin-A1
- Tyrosine Kinase Receptor-Activated Signal Transduction Pathways Which Lead to Oncogenesis
- Mechanisms of Activation of Receptor Tyrosine Kinases: Monomers Or Dimers
- Tyrosine Kinase Receptors in Oncology
- Co-Targeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma